CDMOs

News

Samsung Biologics has agreed to buy PolyPeptide, a Swiss CDMO, in what is thought to be South Korea's largest biopharma acquisition to date.

R&D

For CROs and CDMOs, automation is key to ensuring long-term success.

R&D

Saudi Arabia is steadily establishing itself as a competitive worldwide destination for contract development and manufacturing.

News

Oxford BioMedica confirmed this morning that it has received an unsolicited approach from private equity group EQT about a possible takeover.

R&D

Sigma Mostafa, CSO at KBI BioPharma, discusses the role of CDMOs and the important factors companies should consider when selecting one.

R&D

Today, the demand for speed, quality, and scalability is pushing the industry towards a different model: integrated manufacturing.